Methyllycaconitine citrate
Methyllycaconitine citrate (MLA) is a potent and selective antagonist of the α7 nicotinic acetylcholine receptor (α7nAChR) with the ability to cross the blood-brain barrier. It is widely used as a pharmacological tool in neuroscience research to investigate receptor function in both in vitro binding assays and in vivo behavioral studies.
Product Specifications
CAS Number
351344-10-0
Product Name Alternative
α7 nAChR, MLA
Field of Research
Neuroscience
Purity
98.03% (May vary between batches)
Solubility
H2O:1 mg/mL (1.14 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (4.57 mM) ; DMSO:100 mg/mL (114.3 mM)
Smiles
OC (=O) CC (O) (CC (O) =O) C (O) =O.[H][C@]12C[C@]3 ([H]) [C@] ([H]) ([C@H]1OC) [C@] (O) (C[C@@H]2OC) C1 (O) [C@@H] (OC) [C@@]2 ([H]) C33C1N (CC) C[C@]2 (COC (=O) c1ccccc1N1C (=O) C[C@H] (C) C1=O) CC[C@@H]3OC
Molecular Formula
C43H58N2O17
Molecular Weight
874.92
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62605R-APC-Cy5.5 100 µL
Cip4 Recombinant Antibody, APC-Cy5.5 Conjugated
Sign In for Pricing
View Details 
bsm-54237R-Cy5-01 20 µL
GABBR2 Recombinant Antibody, Cy5 Conjugated
Sign In for Pricing
View Details